A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback